SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)
NCT00739674
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
992
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
losartan potassium (+ hydrochlorothiazide [HCTZ] + calcium channel blocker [CCB])
BEHAVIORAL:
Low Salt Diet
Sponsor
Organon and Co